Taipei Exchange - Delayed Quote TWD

BenQ Medical Technology Corporation (4116.TWO)

41.70
+0.25
+(0.60%)
At close: 1:13:46 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,938,161
4,767,352
4,543,001
2,951,360
1,464,594
Cost of Revenue
3,406,048
3,318,988
3,199,099
2,091,111
952,311
Gross Profit
1,532,113
1,448,364
1,343,902
860,249
512,283
Operating Expense
1,186,920
1,114,971
979,128
681,126
463,227
Operating Income
345,193
333,393
364,774
179,123
49,056
Net Non Operating Interest Income Expense
-26,282
-22,995
-17,728
-11,295
-3,223
Pretax Income
339,594
329,381
373,098
274,890
61,783
Tax Provision
97,014
92,128
109,906
38,293
12,747
Net Income Common Stockholders
104,411
104,831
114,581
180,244
28,840
Diluted NI Available to Com Stockholders
104,411
104,831
114,581
180,244
28,840
Basic EPS
2.34
2.35
2.57
4.04
0.65
Diluted EPS
2.33
2.34
2.56
4.02
0.65
Basic Average Shares
44,578.53
44,566
44,566
44,566
44,566
Diluted Average Shares
44,838.53
44,826
44,819
44,848
44,660
Total Expenses
4,592,968
4,433,959
4,178,227
2,772,237
1,415,538
Net Income from Continuing & Discontinued Operation
104,411
104,831
114,581
180,244
28,840
Normalized Income
103,828.11
105,099.67
114,112.60
178,732.62
30,260.69
Interest Income
11,184
11,228
10,213
2,210
689
Interest Expense
37,466
34,223
27,941
13,505
3,912
Net Interest Income
-26,282
-22,995
-17,728
-11,295
-3,223
EBIT
377,060
363,604
401,039
288,395
65,695
EBITDA
639,845
618,818
630,261
478,402
166,738
Reconciled Cost of Revenue
3,406,048
3,318,988
3,199,099
2,091,111
952,311
Reconciled Depreciation
262,785
255,214
229,222
190,007
101,043
Net Income from Continuing Operation Net Minority Interest
104,411
104,831
114,581
180,244
28,840
Total Unusual Items Excluding Goodwill
816
-373
664
1,756
-1,790
Total Unusual Items
816
-373
664
1,756
-1,790
Normalized EBITDA
639,029
619,191
629,597
476,646
168,528
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
233.11
-104.33
195.60
244.62
-369.31
12/31/2021 - 12/31/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers